- Home
- Publications
- Publication Search
- Publication Details
Title
Dasatinib as a treatment for Duchenne muscular dystrophy
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 25, Issue 2, Pages 266-274
Publisher
Oxford University Press (OUP)
Online
2015-11-25
DOI
10.1093/hmg/ddv469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bortezomib Partially Improves Laminin α2 Chain–Deficient Muscular Dystrophy
- (2014) Zandra Körner et al. AMERICAN JOURNAL OF PATHOLOGY
- Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical–metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy
- (2014) Giulia Maria Camerino et al. HUMAN MOLECULAR GENETICS
- Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy
- (2014) T. A. Waugh et al. HUMAN MOLECULAR GENETICS
- Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD Dogs
- (2013) Karla P. C. Araujo et al. PLoS One
- Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer
- (2013) G. Mathew et al. Scientific Reports
- A role for β-dystroglycan in the organization and structure of the nucleus in myoblasts
- (2012) Ivette A. Martínez-Vieyra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan
- (2012) Jillian M. Rojek et al. CELLULAR MICROBIOLOGY
- Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures
- (2012) S. Baxendale et al. Disease Models & Mechanisms
- Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse
- (2012) Gaynor Miller et al. HUMAN MOLECULAR GENETICS
- MultiDsk: A Ubiquitin-Specific Affinity Resin
- (2012) Marcus D. Wilson et al. PLoS One
- Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer
- (2012) A. Mitchell et al. PROSTATE
- Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
- (2011) Yung-Yao Lin et al. HUMAN MOLECULAR GENETICS
- Drug screening in a zebrafish model of Duchenne muscular dystrophy
- (2011) G. Kawahara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic Potential of Proteasome Inhibition in Duchenne and Becker Muscular Dystrophies
- (2010) Elisabetta Gazzerro et al. AMERICAN JOURNAL OF PATHOLOGY
- Dystroglycan versatility in cell adhesion: a tale of multiple motifs
- (2010) Chris J Moore et al. Cell Communication and Signaling
- Characterization of an Importin α/β-recognized nuclear localization signal in β-dystroglycan
- (2010) Bárbara Lara-Chacón et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy
- (2010) C. M. Adamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Zebrafish: A Complete Animal Model for In Vivo Drug Discovery and Development
- (2009) Chiranjib Chakraborty et al. CURRENT DRUG METABOLISM
- Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin
- (2008) Jeffrey R. Guyon et al. HUMAN MOLECULAR GENETICS
- Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
- (2008) Y-M Chang et al. ONCOGENE
- Dystroglycan, Tks5 and Src Mediated Assembly of Podosomes in Myoblasts
- (2008) Oliver Thompson et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started